Lun Tan

587 total citations
26 papers, 426 citations indexed

About

Lun Tan is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Lun Tan has authored 26 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Organic Chemistry. Recurrent topics in Lun Tan's work include Synthesis and biological activity (5 papers), Cancer therapeutics and mechanisms (4 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Lun Tan is often cited by papers focused on Synthesis and biological activity (5 papers), Cancer therapeutics and mechanisms (4 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Lun Tan collaborates with scholars based in China, United States and Canada. Lun Tan's co-authors include Dao Wen Wang, Jin Huang, Yuxi Wang, Rufei Shen, Jifa Zhang, Yuanxiang Zhao, Houjuan Zuo, Lina Zhang, Lei Liu and Yanyan Cao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Human Molecular Genetics.

In The Last Decade

Lun Tan

25 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lun Tan China 12 205 84 68 60 54 26 426
Valérie Martin France 13 219 1.1× 116 1.4× 75 1.1× 24 0.4× 57 1.1× 17 665
Hidetomo Kitamura Japan 12 240 1.2× 45 0.5× 48 0.7× 107 1.8× 54 1.0× 22 588
Zsolt Kasza Sweden 11 178 0.9× 44 0.5× 23 0.3× 46 0.8× 23 0.4× 15 385
Giuseppe Dell’Elba Italy 11 102 0.5× 106 1.3× 55 0.8× 34 0.6× 14 0.3× 18 483
Ines Macias‐Perez United States 12 180 0.9× 28 0.3× 28 0.4× 78 1.3× 35 0.6× 17 600
Silvia González-Ramos Spain 16 253 1.2× 160 1.9× 66 1.0× 23 0.4× 13 0.2× 21 597
Sophie Beyer United States 9 394 1.9× 139 1.7× 75 1.1× 33 0.6× 31 0.6× 11 687
Jinfu Yang China 12 185 0.9× 59 0.7× 102 1.5× 48 0.8× 10 0.2× 52 387
Barbara Schreier Germany 13 272 1.3× 117 1.4× 41 0.6× 36 0.6× 8 0.1× 33 500
Sumihiko Hagita Japan 8 147 0.7× 94 1.1× 45 0.7× 40 0.7× 9 0.2× 12 404

Countries citing papers authored by Lun Tan

Since Specialization
Citations

This map shows the geographic impact of Lun Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lun Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lun Tan more than expected).

Fields of papers citing papers by Lun Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lun Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lun Tan. The network helps show where Lun Tan may publish in the future.

Co-authorship network of co-authors of Lun Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Lun Tan. A scholar is included among the top collaborators of Lun Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lun Tan. Lun Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chengyong, et al.. (2024). Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapy. European Journal of Medicinal Chemistry. 276. 116649–116649. 5 indexed citations
2.
Zhang, Lele, et al.. (2024). Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy. European Journal of Medicinal Chemistry. 276. 116702–116702. 3 indexed citations
3.
Zhang, Jifa, et al.. (2023). Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors. European Journal of Medicinal Chemistry. 248. 115085–115085. 8 indexed citations
4.
Li, Wenting, Lun Tan, Zhixiong Zhang, et al.. (2021). The X-ray structure of tubulysin analogue TGL in complex with tubulin and three possible routes for the development of next-generation tubulysin analogues. Biochemical and Biophysical Research Communications. 565. 29–35. 2 indexed citations
5.
Li, Wenting, Minhao Huang, Anjie Xia, et al.. (2021). C3 ester side chain plays a pivotal role in the antitumor activity of Maytansinoids. Biochemical and Biophysical Research Communications. 566. 197–203. 8 indexed citations
6.
Tan, Lun, et al.. (2021). Downregulation of SUV39H1 and CITED2 Exerts Additive Effect on Promoting Adipogenic Commitment of Human Mesenchymal Stem Cells. Stem Cells and Development. 30(9). 485–501. 1 indexed citations
7.
Li, Zongzhe, Peng Chen, Chenze Li, et al.. (2019). Genetic arrhythmias complicating patients with dilated cardiomyopathy. Heart Rhythm. 17(2). 305–312. 14 indexed citations
8.
Li, Zongzhe, Chengming Zhou, Lun Tan, et al.. (2018). A targeted sequencing approach to find novel pathogenic genes associated with sporadic aortic dissection. Science China Life Sciences. 61(12). 1545–1553. 18 indexed citations
9.
Huang, Jin, Chenze Li, Ying Song, et al.. (2018). ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure. Cell Discovery. 4(1). 57–57. 25 indexed citations
10.
Marquez, Maribel, Frances Alencastro, Robert Liu, et al.. (2017). The Role of Cellular Proliferation in Adipogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stem Cells. Stem Cells and Development. 26(21). 1578–1595. 53 indexed citations
11.
12.
Tan, Lun, Zongze Li, Chengming Zhou, et al.. (2017). FBN1 mutations largely contribute to sporadic non-syndromic aortic dissection. Human Molecular Genetics. 26(24). 4814–4822. 28 indexed citations
13.
Liu, Lei, et al.. (2017). Increased Cathepsin D Correlates with Clinical Parameters in Newly Diagnosed Type 2 Diabetes. Disease Markers. 2017. 1–6. 26 indexed citations
14.
Huang, Jin, Lun Tan, Rufei Shen, et al.. (2016). Decreased Peripheral Mitochondrial DNA Copy Number is Associated with the Risk of Heart Failure and Long-term Outcomes. Medicine. 95(15). e3323–e3323. 52 indexed citations
15.
Li, Zongzhe, Chengming Zhou, Lun Tan, et al.. (2016). Variants of genes encoding collagens and matrix metalloproteinase system increased the risk of aortic dissection. Science China Life Sciences. 60(1). 57–65. 19 indexed citations
16.
Chaugai, Sandip, Lun Tan, Jin Huang, et al.. (2016). Common variants in IL-17A/IL-17RA axis contribute to predisposition to and progression of congestive heart failure. Medicine. 95(27). e4105–e4105. 25 indexed citations
17.
Liu, Lei, Lun Tan, Jinsheng Lai, Sheng Li, & Dao Wen Wang. (2016). Enhanced Rho-kinase activity: Pathophysiological relevance in type 2 diabetes. Clinica Chimica Acta. 462. 107–110. 11 indexed citations
18.
Liu, Lei, Lun Tan, Jinsheng Lai, Sheng Li, & Dao Wen Wang. (2016). Data for increased Rho kinase activity in type 2 diabetic patients. Data in Brief. 9. 978–982. 1 indexed citations
19.
Liu, Lei, Ling You, Lun Tan, Dao Wen Wang, & Wei Cui. (2015). Genetic insight into the role of MRAS in coronary artery disease risk. Gene. 564(1). 63–66. 6 indexed citations
20.
You, Ling, Lun Tan, Lei Liu, et al.. (2015). ADAMTS7 locus confers high cross-race risk for development of coronary atheromatous plaque. Molecular Genetics and Genomics. 291(1). 121–128. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valérie Martin Breakdown of academic impact, for papers by Hidetomo Kitamura Breakdown of academic impact, for papers by Zsolt Kasza Breakdown of academic impact, for papers by Giuseppe Dell’Elba Breakdown of academic impact, for papers by Ines Macias‐Perez Breakdown of academic impact, for papers by Silvia González-Ramos Breakdown of academic impact, for papers by Sophie Beyer Breakdown of academic impact, for papers by Jinfu Yang Breakdown of academic impact, for papers by Barbara Schreier Breakdown of academic impact, for papers by Sumihiko Hagita
Rankless by CCL
2026